0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Canadian approvals update
Nov. 8, 2007
The Canadian Pest Management Regulatory Agency (PMRA) approved 11 new pesticide active ingredients in the six months to September 30th. They included five for reduced-risk biopesticides, two for non-reduced risk conventional agrochemicals and two for biocides.
Canadian new ai approvals April-Sept 2007(1)
Company ai/product Use
Arysta acequinocyl(2) acaricide for
LifeScience (Shuttle, ornamentals,
Kanemite) nursery crops,
apples & pears
AgraQuest Bacillus subtilis biofungicide for
QST 7133 range of crops
Bayer pyrasulfotole(4) cereal herbicide
CropScience thiacloprid insecticide for
(Calypso) pome fruit
Hercon spruce budworm pheromone for
Environmental pheromone mating disruption
(Hercon Disrupt for forestry
Micro-Flake SBW)
Premier Bacillus subtilis biofungicide for
Horticulture MBI1600(3) ornamentals &
vegetable
transplants
Rode-Trol cellulose(3) rodenticide
4260864 Canada Sclerotinia minor mycoherbicide for
IMI3144141(3) turf
(1) excludes biocides; (2) reduced risk;
(3) reduced-risk biopesticide;
(4) joint review. Source: PMRA.
The PMRA registered 433 uses for new and existing ais in the first half of fiscal 2008, of which 245 were for food use and 188 for non-food use. The total included 382 minor-crop uses and six for major crops. There were 386 agricultural uses and 47 non-agricultural uses.
fiscal 2007
The PMRA registered ten new ais in fiscal 2007, including five biopesticides. The Agency processed 69 category A submissions during the year, of which 40 were registered. This group includes new ais and their end-use products as well as major new uses, applications to establish maximum residue limits for new ais, and user-requested minor-use registrations. A total of 6,907 submissions were processed in all categories, including new uses and product amendments. There were 6,444 registrations granted for category B-E submissions.
Source: AgroNews
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER